Cheminova  
skin-cap
  Borozin
Relaxnova
Epigen

EPIGEN CLINICAL STUDIES

Back

In this page, you will find information on clinical studies carried out in many countries all over the world by dermatologists with proved experience. For any additional information please feel free to contact us. Cheminova Internacional, S.A. See more clinical studies on EPIGEN

Antiviral activity of a D-Glycyrrhizin derivative against herpetic ulcers (HSV type 2) in rabbit cornea

Epigen antiviral activity Epigen antiviral activity
Control of HSV-2 with non-activated
Clycyrrhizin after 4 days of viral infection
  Control of HSV-2 with non activated
Glycyrrhizin after 14 days of viral infection
Epigen antiviral activity   Epigen antiviral activity
After 4 days treatment with activated
Glycyrrhizin
  After 14 days of treatment wit activated
Glycyrrhizin
Epigen antiviral activity   Epigen antiviral activity
After 4 days treatmen Acyclovir   After 14 days treatment Acyclovir
Centro de Investigaciones Biológicas (Virología)
Dra. Pilar Vilas
Madrid (Spain)

Contactar Comprar

 

Gynaecological Centre “SALUD Y MUJER” ( “HEALTH AND WOMAN”)
Dr. O. Martín Crevillente
Madrid / SPAIN

No. of patients: 22 with Papilloma Virus.

All the patients responded well to the treatment with EPIGEN, which may be considered an effective ANTIVIRAL AGENT for the treatment of the Papilloma Virus in the external genital organs, vulva and vagina.

No. of patients: 20 with Genital Herpes.

Complete remission in 18 patients. The two remaining cases are HIV positive.back to top

Gynaecological Centre “SALUD Y MUJER” ( “HEALTH AND WOMAN”)
Clinical Study of the Preparation “EPIGEN labial”
Dr. O. Martín Crevillente
Madrid / SPAIN

No. of patients: 25 with Type I Herpes Simplex.

Clinical effectiveness and tolerance.
Excellent results in all the treated patients.back to top

MOSCOW MEDICAL ACADEMY
I.M. Sechenov
Prof. Y. Ya Shakhtmeister
Head of Laboratory
Moscow / RUSSIA

No. of patients: 30 with Herpes Simplex, Progenital Herpes, Recurrent Herpes and Herpes Zoster.

High ANTIVIRAL effectiveness of the preparation EPIGEN, together with good tolerance.
Treatment of 4 to 10 days.
Recommended for its registration in Russia, with a wide range of clinical uses.
High effectiveness against Genital Herpes.
No side effects and good tolerance.
Appropriate for skin and mucous membranes.back to top

HOSPITAL GENERAL DE MÉXICO
Dr. Manuel Gea González
Dr. Rodolfo Vick Fragosa
México / MÉXICO

No. of patients: 150 with Genital Herpes.

We consider that treatment with EPIGEN may be a good alternative for Genital Herpes as an initial infection (100%) and as well in recurrent cases (90%).back to top

MINISTRY OF HEALTH
Central Dermatovenereal Scientific Research Institute
Prof. Yu. K. Skripkin
Moskow / RUSSIA

No. of patients: 30 with genital herpes

Improvement in 100 % of the treated cases (significant improvement in 73.3 % of the cases and good improvement in 26.7 % of the cases)
EPIGEN is a highly effective preparation for the treatment of genital herpes, both at the initial stages and on recurrence.back to top

MINISTRY OF PUBLIC HEALTH
State University of Medicine
Prof. Norotki
Moscow / RUSSIA

No. of patients: 4 patients with genital herpes

EPIGEN is an effective new medicine for the treatment of the topical forms of genital herpes, showing a quick clinical action and obtaining a durable remission.back to top

RUSSIAN MEDICAL STATE UNIVERSITY
Department of Dermatovenereal Diseases
Moscow / RUSSIA

No. of patients: 30 patients with urogenital herpes

Good tolerance
Highly effective
Complete clinical recovery in 80 % of the treated cases
EPIGEN is to be considered a highly effective new agent for the treatment of urogenital herpes.back to top

Prof. V. N. Prilepskaya
Prof. G. T. Suhih
RUSSIA

No. of women patients: 18 with papilloma virus
14 with genital herpes

The preliminary conclusions of the clinical study give evidence of the good results of EPIGEN to treat inflammation, with analgesic and antiviral effects in patients with papilloma and herpes virus.
EPIGEN is highly recommended.back to top

CENTRAL SCIENTIFIC RESEARCH INSTITUTE
OF DERMATOVENEREAL DISEASES
Prof. Bogatyreva
Moscow / RUSSIA

No. of patients: 30 with papilloma virus

Antiviral, immunomodulating and anti-inflammatory actions
Complete clinicial recovery in all the treated cases
The use of EPIGEN is particularly effective for initial lesions without preliminary treatment.back to top

   
skin-cap spray skin-cap shampoo skin-cap cream